Shentracon Chemicals Limited has announced the relocation of its registered office within Kolkata following a board meeting held on March 18, 2026. The decision was approved by the company's Board of Directors in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Office Relocation Details

The company will shift its registered office from the current location to a new address within the same city. The relocation involves moving from a traditional business area to the central Dharmatala district of Kolkata.

Updated Contact Information

Along with the office relocation, Shentracon Chemicals has updated its primary contact details to reflect the new operational setup. The company has transitioned to new communication channels to ensure seamless connectivity with stakeholders.

Board Meeting Proceedings

The board meeting was conducted on March 18, 2026, under the chairmanship of Managing Director Amit Lalit Jain (DIN: 05263766). The meeting was efficiently conducted within a 30-minute timeframe, commencing at 05:30 PM and concluding at 06:00 PM.

Regulatory Compliance

The company has formally communicated this development to BSE Limited through official channels. The intimation was made pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Shentracon Chemicals Limited has requested BSE to disseminate this information through appropriate channels to ensure all stakeholders are informed about the registered office relocation and updated contact details.

Shentracon Chemicals Limited has successfully concluded its Board of Directors meeting on February 13, 2026, where the board considered and approved the unaudited standalone financial results for the quarter and nine months ended December 31, 2025. The meeting, which was previously scheduled and announced on February 9, 2026, was conducted in accordance with regulatory requirements.

Board Meeting Outcome

The Board of Directors meeting commenced at 5:00 p.m. and concluded at 5:40 p.m. on February 13, 2026. During the meeting, the board reviewed and approved the company's unaudited standalone financial results for the third quarter of fiscal year 2026 and the nine-month period ending December 31, 2025.

Regulatory Compliance and Documentation

The financial results have been reviewed by the company's Audit Committee and are accompanied by a Limited Review Report issued by the Statutory Auditors. The company has submitted the approved financial results along with the auditor's report to stock exchanges as required under regulatory guidelines.

Stock Exchange Communication

Shentracon Chemicals Limited has formally communicated the outcome to BSE Limited (Scrip Code: 530757) and The Calcutta Stock Exchange Ltd (Scrip Code: 29095). The company has requested both exchanges to disseminate this information on their respective websites as deemed appropriate.

Company Information

Shentracon Chemicals Limited operates under CIN L24299WB1993PLC059449 with its registered office at 6A, Kiran Sankar Roy Road, Kolkata-700001. The communication was digitally signed by Amit Lalit Jain, Managing Director (DIN: 05263766), at 6:10 p.m. on February 13, 2026, confirming the completion of the board meeting and approval of financial results.